4.5 Article

Successful management of an MRSA outbreak in a neonatal intensive care unit

Publisher

SPRINGER
DOI: 10.1007/s10096-011-1175-4

Keywords

-

Ask authors/readers for more resources

We report an MRSA outbreak in our 25-bed tertiary neonatal intensive care unit (NICU), which was successfully contained. Methods include a retrospective review of patient files, microbiology records and meeting protocols. During the seven months of outbreak, 27 patients and seven health care workers (HCWs) had positive cultures for MRSA. The outbreak was caused by the epidemic Rhine-Hessen strain; cultured isolates were monoclonal. After a sharp increase of the number of new MRSA-cases the installation of an outbreak management team (OMT) and implementation of comprehensive measures (extensive screening and decolonization strategy including orally applied vancomycin, isolation wards, intensive disinfection regimen) successfully terminated the outbreak within one month. Ten (53%) of 19 patients with completed follow-up and all of the HCWs were decolonized successfully. Gastrointestinal colonization was present in 15 of 27 (56%) neonates, and was associated with poor decolonization success (30% vs. 78% in absence of gastrointestinal colonization). A comprehensive outbreak management can terminate an outbreak in a NICU setting within a short time. Thorough screening of nares, throat and especially stool is necessary for correct cohorting. Gastrointestinal decolonization in neonates seems difficult.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

Elin M. Svensson, Robin J. Svensson, Lindsey H. M. te Brake, Martin J. Boeree, Norbert Heinrich, Sarah Konsten, Gavin Churchyard, Rodney Dawson, Andreas H. Diacon, Gibson S. Kibiki, Lilian T. Minja, Nyanda E. Ntingiya, Ian Saone, Stephen H. Gillespie, Michael Hoelscher, Patrick P. J. Phillips, Ulrika S. H. Simonsson, Rob Aarnoutse

CLINICAL INFECTIOUS DISEASES (2018)

Article Infectious Diseases

Seroepidemiological and molecular investigations of infections with Crimean-Congo haemorrhagic fever virus in Kazakhstan

Karlygash Abdiyeva, Nurkeldi Turebekov, Andrey Dmitrovsky, Nur Tukhanova, Anna Shin, Lyazat Yeraliyeva, Norbert Heinrich, Michael Hoelscher, Ravilya Yegemberdiyeva, Zhanna Shapiyeva, Zulfiya Kachiyeva, Aliya Zhalmagambetova, Josef Montag, Gerhard Dobler, Josua Zinner, Edith Wagner, Stefan Frey, Sandra Essbauer

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)

Article Infectious Diseases

Protein binding of rifampicin is not saturated when using high-dose rifampicin

Carlijn H. C. Litjens, Rob E. Aarnoutse, Eleonora W. J. van Ewijk-Beneken Kolmer, Elin M. Svensson, Angela Colbers, David M. Burger, Martin J. Boeree, Lindsey H. M. te Brake, Rob Aarnoutse, Martin Boeree, Norbert Heinrich, Andreas Diacon, Rodney Dawson, Sunita Rehal, Gibson Kibiki, Gavin Churchyard, Ian Sanne, Nyanda Ntinginya, Lilian Minja, Robert Hunt, Salome Charalambous, Madeleine Hanekom, Hadija Semvua, Stellah Mpagama, Christina Manyama, Bariki Mtafya, Klaus Reither, Robert Wallis, Amour Venter, Kim Narunsky, Anna-Maria Mekota, Sonja Henne, Georgette Plemper van Balen, Stephen Gillespie, Patrick Phillips, Michael Hoelscher

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Article Multidisciplinary Sciences

A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB

Markus Beutler, Sara Plesnik, Marina Mihalic, Laura Olbrich, Norbert Heinrich, Samuel Schumacher, Michael Lindner, Ina Koch, Wolfgang Grasse, Christoph Metzger-Boddien, Sabine Hofmann-Thiel, Harald Hoffmann

PLOS ONE (2020)

Article Respiratory System

Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay

Wilber Sabiiti, Khalide Azam, Eoghan Charles William Farmer, Davis Kuchaka, Bariki Mtafya, Ruth Bowness, Katarina Oravcova, Isobella Honeyborne, Dimitrios Evangelopoulos, Timothy Daniel McHugh, Celso Khosa, Andrea Rachow, Norbert Heinrich, Elizabeth Kampira, Geraint Davies, Nilesh Bhatt, Elias N. Ntinginya, Sofia Viegas, Ilesh Jani, Mercy Kamdolozi, Aaron Mdolo, Margaret Khonga, Martin J. Boeree, Patrick P. J. Phillips, Derek Sloan, Michael Hoelscher, Gibson Kibiki, Stephen H. Gillespie

THORAX (2020)

Article Microbiology

Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-ResistantSalmonella entericaand Methicillin-ResistantStaphylococcus aureusAmong Febrile Patients in Sub-Saharan Africa

Rehema Moraa Moirongo, Eva Lorenz, Nyanda E. Ntinginya, Denise Dekker, Jose Fernandes, Jana Held, Maike Lamshoeft, Frieder Schaumburg, Chacha Mangu, Lwitiho Sudi, Ali Sie, Aurelia Souares, Norbert Heinrich, Andreas Wieser, Benjamin Mordmueller, Ellis Owusu-Dabo, Akim Ayola Adegnika, Boubacar Coulibaly, Juergen May, Daniel Eibach

FRONTIERS IN MICROBIOLOGY (2020)

Article Pharmacology & Pharmacy

A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis

Stijn W. van Beek, Rob ter Heine, Jan-Willem C. Alffenaar, Cecile Magis-Escurra, Rob E. Aarnoutse, Elin M. Svensson

Summary: This study developed a population pharmacokinetic model for isoniazid and tested several limited sampling strategies for model-based therapeutic drug monitoring. The strategy sampling at 2 and 4 hours after dosing was determined as the most suitable for predicting AUC(24) and peak concentration. Further evaluation in a clinical setting is needed to confirm the performance of this strategy.

CLINICAL PHARMACOKINETICS (2021)

Article Respiratory System

Optimising pyrazinamide for the treatment of tuberculosis

Nan Zhang, Radojka M. Savic, Martin J. Boeree, Charles A. Peloquin, Marc Weiner, Norbert Heinrich, Erin Bliven-Sizemore, Patrick P. J. Phillips, Michael Hoelscher, William Whitworth, Glenn Morlock, James Posey, Jason E. Stout, William Mac Kenzie, Robert Aarnoutse, Kelly E. Dooley

Summary: Pyrazinamide is a potent sterilizing agent that can shorten the treatment duration for tuberculosis, and its optimal dose remains uncertain. Higher blood concentrations of pyrazinamide are associated with faster culture conversion time and higher conversion probability. Optimizing the use of pyrazinamide may enhance its microbiologic efficacy, but increasing the dose alone may not be enough to shorten tuberculosis treatment, requiring parallel increases in rifampicin dose.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Respiratory System

Increased bactericidal activity but dose-limiting intolerability at 50 mg.kg-1 rifampicin

Lindsey H. M. te Brake, Veronique de Jager, Kim Narunsky, Naadira Vanker, Elin M. Svensson, Patrick P. J. Phillips, Stephen H. Gillespie, Norbert Heinrich, Michael Hoelscher, Rodney Dawson, Andreas H. Diacon, Rob E. Aamoutse, Martin J. Boeree

Summary: The study evaluated the safety, tolerability, pharmacokinetics, and early bactericidal activity of increasing doses of rifampicin in treatment-naive adult smear-positive patients with tuberculosis. While the 50mg/kg dose showed an increased bactericidal effect, it was not well tolerated, leading to treatment discontinuations, whereas the 40mg/kg dose was well tolerated and selected for further evaluation.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Public, Environmental & Occupational Health

Molecular epidemiology of respiratory syncytial virus in children in sub-Saharan Africa

Clara Marlene Ihling, Paul Schnitzler, Norbert Heinrich, Chacha Mangu, Lwitiho Sudi, Aurelia Souares, Sabine Gies, Ali Sie, Boubacar Coulibaly, Andiyam Thierry Ouedraogo, Benjamin Mordmueller, Jana Held, Ayola Akim Adegnika, Jose F. Fernandes, Isabella Eckerle, Juergen May, Benedikt Hogan, Daniel Eibach, Julia Tabatabai

Summary: This study investigated the molecular epidemiology of respiratory syncytial virus (RSV) among febrile children with acute respiratory tract infection in several sub-Saharan African countries. The results showed RSV A strains clustering with genotype ON1 and RSV B strains belonging to genotype BAIX. Phylogenetic analysis revealed diversification of RSV strains into different lineages in sub-Saharan Africa.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2021)

Correction Pharmacology & Pharmacy

A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis (February, 10.1007/s40262-020-00971-2, 2021)

Stijn W. van Beek, Rob ter Heine, Jan-Willem C. Alffenaar, Cecile Magis-Escurra, Rob E. Aarnoutse, Elin M. Svensson

CLINICAL PHARMACOKINETICS (2021)

Review Microbiology

Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies

Jan Heyckendorf, Sophia B. Georghiou, Nicole Frahm, Norbert Heinrich, Irina Kontsevaya, Maja Reimann, David Holtzman, Marjorie Imperial, Daniela M. Cirillo, Stephen H. Gillespie, Morten Ruhwald

Summary: Despite advancements in diagnostics, drugs, and regimens, tuberculosis remains a major global health threat. The current methods for monitoring TB treatment and determining treatment success have limitations. However, molecular technologies and assays show promise as suitable alternatives, which can potentially revolutionize TB therapy monitoring and expedite drug development.

CLINICAL MICROBIOLOGY REVIEWS (2022)

Article Biotechnology & Applied Microbiology

Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania

Beatrice Kemilembe Mutayoba, Michael Hoelscher, Norbert Heinrich, Moses L. Joloba, Eligius Lyamuya, Andrew Martin Kilale, Nyagosya Segere Range, Bernard James Ngowi, Nyanda Elias Ntinginya, Saidi Mwinjuma Mfaume, Amani Wilfred, Basra Doulla, Johnson Lyimo, Riziki Kisonga, Amri Kingalu, Jupiter Marina Kabahita, Ocung Guido, Joel Kabugo, Isa Adam, Moses Luutu, Maria Magdalene Namaganda, Joanitah Namutebi, George William Kasule, Hasfah Nakato, Henry Byabajungu, Pius Lutaaya, Kenneth Musisi, Denis Oola, Gerald Mboowa, Michel Pletschette

Summary: The study found that Lineage 3 is the most prevalent lineage in Tanzania, while drug-resistant mutations were more common among isolates belonging to Lineage 4.

BMC GENOMICS (2022)

Article Immunology

Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse

Nyanda Elias Ntinginya, Abhishek Bakuli, Daniel Mapamba, Wilber Sabiiti, Gibson Kibiki, Lilian Tina Minja, Davis Kuchaka, Klaus Reither, Patrick Peter John Phillips, Martin Johan Boeree, Stephen H. Gillespie, Michael Hoelscher, Norbert Heinrich

Summary: Bacterial killing in patients with tuberculosis relapse differs significantly from that in patients achieving cure, as evidenced by TB-MBLA and MGIT TTP measurements.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Diagnosis of paediatric TB using Xpert® MTB/RIF Ultra on fresh respiratory samples

I Sabi, W. Olomi, E. Nkereuwem, T. Togun, M. P. Gomez, M. Sylla, B. Diarra, M. Sanogo, E. Sichone, H. Mahiga, F. Njeleka, A. O. Ebonyi, U. Egere, N. E. Ntinginya, M. Hoelscher, N. Heinrich, B. Kampmann

Summary: The study evaluated the diagnostic accuracy of Xpert(R) MTB/RIF Ultra in fresh respiratory samples for the diagnosis of pulmonary TB in children. While Ultra showed improved performance compared to Xpert, its sensitivity remains sub-optimal for TB detection in children, with an additional 20 cases detected in the group with negative culture results, suggesting that culture may not be a perfect reference standard.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)

No Data Available